AGC Biologics partners with Novelty Nobility for Cell Line Development and Phase I Preparations of Antibody Drug Candidate
AGC Biologics partners with Novelty Nobility for Cell Line Development and Phase I Preparations of Antibody Drug Candidate
05/06/25, 1:11 AM
Location
bothellIndustry
biotechnology
health care
Type
partnership
AGC Biologics has announced a multiphase partnership with Novelty Nobility Inc. to leverage its expertise and proprietary CHEF1® expression technology for cell line development and Phase I clinical trials. The partnership will involve work at AGC Biologics’ facilities in Copenhagen, Denmark and Chiba, Japan.
Company Info
Location
bothell, washington, united states
Additional Info
AGC Biologics offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics (using mammalian and microbial systems), mRNA, pDNA, viral vector and cell therapy products, from pre-clinical to commercial production, including our proprietary CHEF1TM Expression System for efficient protein production with CHO cells.
Related People
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Ah
Ah • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Ch
Ch • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more